{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T20:08:48Z","timestamp":1768075728532,"version":"3.49.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"crossref","award":["MOST 110-2314-B-002-053-MY3"],"award-info":[{"award-number":["MOST 110-2314-B-002-053-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH 110-MM022-4, and NTUH 111-S0248"],"award-info":[{"award-number":["NTUH 110-MM022-4, and NTUH 111-S0248"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>While corticosteroids have been hypothesized to exert protective benefits in patients infected with SARS-CoV-2, data remain mixed. This study sought to investigate the outcomes of methylprednisone administration in an Italian cohort of hospitalized patients with confirmed SARS-CoV-2 infection.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Patients with confirmatory testing for SARS-CoV-2 were retrospectively enrolled from a tertiary university hospital in Milan, Italy from March 1st to April 30th, 2020 and divided into two groups by administration of corticosteroids. Methylprednisolone was administered to patients not responding to pharmacological therapy and ventilatory support at 0.5-1mg\/kg\/day for 4 to 7 days. Inverse probability of treatment weighting (IPTW) was used to adjust for baseline differences between the steroid and non-steroid cohorts via inverse probability of treatment weight. Primary outcomes included acute respiratory failure (ARF), shock, and 30-day mortality among surviving patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Among 311 patients enrolled, 71 patients received steroids and 240 did not receive steroids. The mean age was 63.1 years, 35.4% were female, and hypertension, diabetes, heart disease, and chronic pulmonary disease were present in 3.5%, 1.3%, 14.8% and 12.2% respectively. Crude analysis revealed no statistically significant reduction in the incidence of 30-day mortality (36,6% vs 21,7%; OR, 2.09; 95% CI, 1.18\u20133.70; p = 0.011), shock (2.8% vs 4.6%; OR, 0.60; 95% CI = 0.13\u20132.79; p = 0.514) or ARF (12.7% vs 15%; OR, 0.82; 95% CI = 0.38\u20131.80; p = 0.625) between the steroid and non-steroid groups. After IPTW analysis, the steroid-group had lower incidence of shock (0.9% vs 4.1%; OR, 0.21; 95% CI,0.06\u20130.77; p = 0.010), ARF (6.6% vs 16.0%; OR, 0.37; 95% CI, 0.22\u20130.64; p&lt;0.001) and 30-day mortality (20.3% vs 22.8%; OR 0.86; 95% CI, 0.59\u20131.26 p = 0.436); even though, for the latter no statistical significance was reached. Steroid use was also associated with increased length of hospital stay both in crude and IPTW analyses. Subgroup analysis revealed that patients with cardiovascular comorbidities or chronic lung diseases were more likely to be steroid responsive. No significant survival benefit was seen after steroid treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Physicians should avoid routine methylprednisolone use in SARS-CoV-2 patients, since it does not reduce 30-day mortality. However, they must consider its use for severe patients with cardiovascular or respiratory comorbidities in order to reduce the incidence of either shock or acute respiratory failure.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0266901","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T17:34:46Z","timestamp":1655487286000},"page":"e0266901","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of methylprednisolone treatment on COVID-19: An inverse probability of treatment weighting analysis"],"prefix":"10.1371","volume":"17","author":[{"given":"Lorenzo","family":"Porta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sih-Shiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Hua","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6677-0951","authenticated-orcid":true,"given":"Wan-Ting","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1243-2463","authenticated-orcid":true,"given":"Chien-Chang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"issue":"13","key":"pone.0266901.ref001","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia","volume":"382","author":"Q Li","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0266901.ref002","unstructured":"WHO | Novel Coronavirus\u2013China [Internet]. WHO. World Health Organization; [cited 2020 Jun 18]. Available from: http:\/\/www.who.int\/csr\/don\/12-january-2020-novel-coronavirus-china\/en\/"},{"issue":"8","key":"pone.0266901.ref003","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019.","volume":"382","author":"N Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0266901.ref004","unstructured":"Coronavirus COVID-19 (2019-nCoV) [Internet]. [cited 2020 Jun 18]. Available from: https:\/\/www.arcgis.com\/apps\/opsdashboard\/index.html#\/bda7594740fd40299423467b48e9ecf6"},{"issue":"4","key":"pone.0266901.ref005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"KG Andersen","year":"2020","journal-title":"Nat Med"},{"issue":"4","key":"pone.0266901.ref006","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Z Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"pone.0266901.ref007","unstructured":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 | NEJM [Internet]. [cited 2020 Jun 19]. Available from: https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2015432?query=recirc_curatedRelated_article"},{"issue":"6","key":"pone.0266901.ref008","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1086\/506430","article-title":"Acute Respiratory Distress Syndrome and Pneumonia: A Comprehensive Review of Clinical Data","volume":"43","author":"TT Bauer","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"10229","key":"pone.0266901.ref009","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"F Zhou","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"pone.0266901.ref010","article-title":"An Update on Current Therapeutic Drugs Treating COVID-19.","author":"R Wu","year":"2020","journal-title":"Curr Pharmacol Rep [Internet]"},{"issue":"11","key":"pone.0266901.ref011","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial","volume":"324","author":"CD Spinner","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"pone.0266901.ref012","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/07853890.2020.1839959","article-title":"Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019","volume":"53","author":"P Bansal","year":"2021","journal-title":"Ann Med."},{"issue":"1","key":"pone.0266901.ref013","first-page":"19","article-title":"Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis","volume":"27","author":"T Fiolet","year":"2021","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"8","key":"pone.0266901.ref014","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","volume":"8","author":"PM George","year":"2020","journal-title":"Lancet Respir Med"},{"key":"pone.0266901.ref015","article-title":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.","author":"C Wu","year":"2020","journal-title":"JAMA Intern Med [Internet]."},{"issue":"6","key":"pone.0266901.ref016","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02808-2020","article-title":"Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial","volume":"56","author":"M Edalatifard","year":"2020","journal-title":"Eur Respir J"},{"issue":"6490","key":"pone.0266901.ref017","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"JB Moore","year":"2020","journal-title":"Science"},{"key":"pone.0266901.ref018","article-title":"GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia.","author":"L Corral","year":"2020","journal-title":"medRxiv."},{"issue":"3","key":"pone.0266901.ref019","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"J Villar","year":"2020","journal-title":"Lancet Respir Med"},{"key":"pone.0266901.ref020","article-title":"Corticosteroid therapy for sepsis: a clinical practice guideline","author":"F Lamontagne","year":"2018","journal-title":"BMJ [Internet]."},{"issue":"1","key":"pone.0266901.ref021","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jinf.2006.01.005","article-title":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong","volume":"54","author":"LY-C Yam","year":"2007","journal-title":"J Infect"},{"issue":"5","key":"pone.0266901.ref022","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/thx.2003.014076","article-title":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak","volume":"59","author":"JJY Sung","year":"2004","journal-title":"Thorax"},{"key":"pone.0266901.ref023","unstructured":"Dexamethasone in Hospitalized Patients with Covid-19\u2014Preliminary Report | NEJM [Internet]. [cited 2020 Aug 15]. Available from: https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2021436"},{"issue":"3","key":"pone.0266901.ref024","first-page":"183","article-title":"Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia","volume":"43","author":"JP Zhao","year":"2020","journal-title":"Zhonghua Jie He Hu Xi Za Zhi Zhonghua Jiehe He Huxi Zazhi Chin J Tuberc Respir Dis"},{"key":"pone.0266901.ref025","unstructured":"Frontiers | Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature | Medicine [Internet]. [cited 2020 Jun 21]. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.00170\/full"},{"issue":"6","key":"pone.0266901.ref026","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41375-020-0848-3","article-title":"Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis","volume":"34","author":"H Li","year":"2020","journal-title":"Leukemia"},{"key":"pone.0266901.ref027","article-title":"Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With COVID-19 (Metcovid): A Randomised, Double-Blind, Phase IIb, Placebo-Controlled Trial","author":"CMP Jeronimo","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"pone.0266901.ref028","doi-asserted-by":"crossref","first-page":"m1936","DOI":"10.1136\/bmj.m1936","article-title":"Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review","volume":"369","author":"A Dagens","year":"2020","journal-title":"BMJ"},{"key":"pone.0266901.ref029","unstructured":"Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China\u2014PubMed [Internet]. [cited 2020 Dec 30]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32880390\/"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T17:35:11Z","timestamp":1655487311000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266901"}},"subtitle":[],"editor":[{"given":"Tariq Jamal","family":"Siddiqi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0266901","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]}}}